Saturday, October 31, 2026

Suzy Stuns with Striking New Photos as She Promotes Upcoming Digital Single ‘Come Back’

Suzy captivates fans with stunning photos promoting her digital single "Come Back," showcasing her beauty and charm. Release on February 17.

Parents Still Parenting? Doctors Say It’s Time for a Checkup

Many elderly Koreans care for grandchildren, risking their health. Early detection of diseases is vital for their well-being.

North Korea’s Kang Kun: What Does the New 5,000-ton Warship Mean for Naval Nuclear Power?

North Korea's new destroyer, Kang Kon, nears commissioning, enhancing naval capabilities but faces infrastructure challenges.

News1

Author's Latest

LigasChem Bio Unveils Preclinical Data on Multiple Myeloma ADC, Plans U.S. Clinical Trial Application This Year

LigasChem Bio reported that its next-generation BCMA-targeted ADC LCB43 showed strong antitumor activity and favorable tolerability in preclinical studies and plans to file for a U.S. clinical trial this year.

After 19-Year Push, HLB Wins First FDA Drug Approval With More Cancer Programs Ahead

HLB has secured its first U.S. Food and Drug Administration-approved drug after 19 years of development efforts, with follow-up programs in liver cancer, corneal disease and CAR-T therapies underway.

“Doctors Take Patients by the Hand to the Next Exam Room”: The Cancer Center’s Secret to 20-Year Relationships

Korea University Guro Hospital’s cancer center emphasizes long-term patient relationships and close multidisciplinary care, with doctors working directly across specialties from diagnosis through treatment, survivorship and hospice care.

Cancer Survivors Generally Have Healthier Diets, but Quality Declines With Age Among Those Diagnosed Young

A study found that cancer survivors generally have healthier diets than the general population, but those diagnosed with cancer at a younger age tend to experience a decline in diet quality as they grow older.

Alteogen Strengthens Keytruda SC Exclusivity With European Composition Patent

Alteogen has secured a European composition patent for the subcutaneous formulation combining its ALT-B4 enzyme with Merck’s Keytruda, strengthening intellectual property protection for the product in Europe.

Fake Social Media Accounts Impersonating South Korean Financial Leaders Raise Fraud Concerns

Impersonation accounts posing as prominent South Korean financial executives and officials are appearing on social media, using real photos, career histories and current business issues to look authentic and potentially facilitate investment scams.

Onconic Therapeutics Begins Phase 3 Trial of Zastaprazan Injection in China, Secures $1 Million Milestone

Onconic Therapeutics said its Chinese licensing partner Livzon Pharmaceutical Group has begun dosing the first patient in a Phase 3 trial of injectable zastaprazan, triggering a $1 million development milestone.

Lunit SCOPE Study in Hard-to-Treat Cancer Published in Nature Medicine

Lunit’s AI biomarker platform SCOPE was used in a study of first-line treatment for HER2-positive advanced biliary tract cancer that has been published in Nature Medicine.

Interview: Vaim CEO Kim Geun-poong Looks to Patent Technology to Drive Juvelook’s Competitiveness

Vaim founder and manufacturing division CEO Kim Geun-poong says the company aims to build on Juvelook’s patented particle technology to develop a broader range of medical products and eventually expand into pharmaceuticals.

Noeul to Present European Research on AI Blood Analysis for Detecting Abnormal Cells in Leukemia

Noeul will present clinical evidence in Europe for an AI blood analysis technology that can analyze key blood counts and screen for abnormal cells associated with serious blood diseases using just 5 microliters of blood from infants, newborns and children.

Dementia vs. Normal Aging: How to Spot the Differences and Take Action

September 21 is Dementia Overcoming Day, highlighting that dementia affects all age groups due to rapid aging.

Semaglutide and NAION: What Recent Research Reveals About Your Eye Health

Controversy surrounds the rare vision abnormalities linked to semaglutide, the key ingredient in Wegovy and Ozempic.

Ferrari Luce: The First All-Electric Ferrari Featuring Samsung’s OLED Technology

Ferrari occupies prime space in Samsung Display's lobby for a special exhibit showcasing OLED panels in its first electric car, Luce.

LG Partners with Microsoft and Nvidia: What This Means for AI Data Centers in 2026

LG accelerates its efforts to build an AI ecosystem in collaboration with major global tech giants.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.